Terminalia bentzoë, a Mascarene Endemic Plant, Inhibits Human Hepatocellular Carcinoma Cells Growth In Vitro via G0/G1 Phase Cell Cycle Arrest - Université de La Réunion Access content directly
Journal Articles Pharmaceuticals Year : 2020

Terminalia bentzoë, a Mascarene Endemic Plant, Inhibits Human Hepatocellular Carcinoma Cells Growth In Vitro via G0/G1 Phase Cell Cycle Arrest

Elisabete Pires
  • Function : Author
  • PersonId : 1085082
James Mccullagh
  • Function : Author
  • PersonId : 1085083
Timothy D W Claridge
  • Function : Author
  • PersonId : 1085084
Theeshan Bahorun
  • Function : Author
  • PersonId : 1008535
Wen-Wu Li
  • Function : Author
  • PersonId : 1085085
Vidushi S Neergheen
  • Function : Author
  • PersonId : 1085086

Abstract

Tropical forests constitute a prolific sanctuary of unique floral diversity and potential medicinal sources, however, many of them remain unexplored. The scarcity of rigorous scientific data on the surviving Mascarene endemic taxa renders bioprospecting of this untapped resource of utmost importance. Thus, in view of valorizing the native resource, this study has as its objective to investigate the bioactivities of endemic leaf extracts. Herein, seven Mascarene endemic plants leaves were extracted and evaluated for their in vitro antioxidant properties and antiproliferative effects on a panel of cancer cell lines, using methyl thiazolyl diphenyl-tetrazolium bromide (MTT) and clonogenic cell survival assays. Flow cytometry and comet assay were used to investigate the cell cycle and DNA damaging effects, respectively. Bioassay guided-fractionation coupled with liquid chromatography mass spectrometry (MS), gas chromatography-MS, and nuclear magnetic resonance spectroscopic analysis were used to identify the bioactive compounds. Among the seven plants tested, Terminalia bentzoë was comparatively the most potent antioxidant extract, with significantly (p < 0.05) higher cytotoxic activities. T. bentzoë extract further selectively suppressed the growth of human hepatocellular carcinoma cells and significantly halted the cell cycle progression in the G0/G1 phase, decreased the cells' replicative potential and induced significant DNA damage. In total, 10 phenolic compounds, including punicalagin and ellagic acid, were identified and likely contributed to the extract's potent antioxidant and cytotoxic activities. These results established a promising basis for further in-depth investigations into the potential use of T. bentzoë as a supportive therapy in cancer management.
Fichier principal
Vignette du fichier
pharmaceuticals-13-00303.pdf (1.4 Mo) Télécharger le fichier
Origin Publication funded by an institution

Dates and versions

hal-03048291 , version 1 (09-12-2020)

Licence

Identifiers

Cite

Nawraj Rummun, Philippe Rondeau, Emmanuel Bourdon, Elisabete Pires, James Mccullagh, et al.. Terminalia bentzoë, a Mascarene Endemic Plant, Inhibits Human Hepatocellular Carcinoma Cells Growth In Vitro via G0/G1 Phase Cell Cycle Arrest. Pharmaceuticals, 2020, Anticancer Compounds in Medicinal Plants, 13 (10), pp.303. ⟨10.3390/ph13100303⟩. ⟨hal-03048291⟩
79 View
95 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More